Akèy › Swen Je
Etid klinik pou Swen Je ap rekrite nan Etazini
23 etid pou Swen Je ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Florid7 etid
- Illinois4 etid
- Kalifòni7 etid
- Maryland5 etid
- North Carolina4 etid
- Oregon3 etid
- South Carolina3 etid
- Tennessee3 etid
- Texas4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Screening for Research Participants
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00655096A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07408232Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07482176Natural History, Pathogenesis, and Outcome of Ocular Disorders
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 24, 2026 · NCT02821767Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
Ap rekrite
0 Days – 9 Months · Tout sèks · Mizajou Sep 17, 2026 · NCT07738874SGLT2 Inhibitors in Geographic Atrophy
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07174687Adaptive Optics Retinal Imaging
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 12 a 120 · Tout sèks · Mizajou Aug 10, 2026 · NCT02317328Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07630649APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07434635Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07413172Ocular Blood Flow Imaging for Glaucoma Assessment
Ap rekriteVolontè an sante akeyi
Laj 18 a 88 · Tout sèks · Mizajou Jul 2, 2026 · NCT05726058Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Ap rekriteFaz 3
Laj 6 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06891443A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
Ap rekrite
Laj 19 a 70 · Tout sèks · Mizajou Jun 3, 2026 · NCT04634383Strategies for Improving Linkage-to-Care After Eye Disease Screening
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT06943599RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT07322302Advancing Pediatric Retinal Imaging With Auto-aligned OCT
Ap rekriteVolontè an sante akeyi
1 Month · Tout sèks · Mizajou Mar 25, 2026 · NCT06841575Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Mar 17, 2026 · NCT06911424Assessment of the Ocular Microbiome in Health and Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT05414994Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06934577Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work
Ap rekriteFaz 4
Laj 18 a 75 · Tout sèks · Mizajou Dec 5, 2025 · NCT07266948Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2025 · NCT06112340IRIS Registry: Intelligent Research in Sight Registry
Ap rekriteEtid obsèvasyon
6 Months · Tout sèks · Mizajou Jul 12, 2016 · NCT02485847Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.